Page 96 - Revista 2019
P. 96

Revista de la Asociación Colombiana de Ciencias Biológicas
         issn impreso 0120-4173, issn en línea 2500-7459



                    BRAF(V600E) inhibitors. J Med Chem.;55(11):5220-30.
                17. Chen D, Huang JF, Liu K, Zhang LQ, Yang Z, Chuai ZR, et al. (2014) BRAFV600E mutation and
                    its association with clinicopathological features of colorectal cancer: a systematic review and meta-
                    analysis. PLoS One. 9(3): e90607.
                18. Ritterhouse LL, Barletta JA. (2015) BRAF V600E mutation-specifi c antibody: A review. Semin Diagn
                    Pathol. 32(5):400-8.
                19. Kalady MF, Dejulius KL, Sanchez JA, Jarrar A, Liu X, Manilich E, et al. (2012) BRAF mutations in
                    colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Dis Colon
                    Rectum. 55(2):128-33.
                20. Pritchard CC, Grady WM. (2011) Colorectal cancer molecular biology moves into clinical practice.
                    Gut. 60(1):116-29.
                21. Murcia O, Juarez M, Hernandez-Illan E, Egoavil C, Giner-Calabuig M, Rodriguez-Soler M, et al.
                    (2016) Serrated colorectal cancer: Molecular classifi cation, prognosis, and response to chemotherapy.
                    World J Gastroenterol. 22(13):3516-30.
                22. QIAGEN. QIAGEN KIT, Dneasy – Blood & Tissue Kit. 2013.
                23. Thermo-Fisher S. 2013 Consultado de: http://www.nanodrop.com/Products.aspx
                24. Ghazi S, Berg E, Lindblom A, Lindforss U. (2013) Clinicopathological analysis of colorectal cancer: a
                    comparison between emergency and elective surgical cases. World J Surg Oncol. 11:133.
                25. Domingo E, Ramamoorthy R, Oukrif D, Rosmarin D, Presz M, Wang H, et al. (2013) Use of multi-
                    variate analysis to suggest a new molecular classifi cation of colorectal cancer. J pathol 229(3):441-8.
                26. McKay A, Donaleshen J, Helewa RM, Park J, Wirtzfeld D, Hochman D, et al. (2014) Does young age
                    infl uence the prognosis of colorectal cancer: a population-based analysis. World J Surg Oncol. 12:370.
                27. Millan M, Merino S, Caro A, Feliu F, Escuder J, Francesch T. (2015) Treatment of colorectal cancer in
                    the elderly. World J Gastrointest Oncol. 7(10):204-20.
                28. Dodou D, de Winter JC. (2012) The relationship between distal and proximal colonic neoplasia: a
                    meta-analysis. J Gen Intern Med. 27(3):361-70.
                29. Hansen IO, Jess P. (2012) Possible better long-term survival in left versus right-sided colon cancer - a
                    systematic review. Dan Med J. 59(6): A4444.
                30. Purim O, Gordon N, Brenner B. (2013) Cancer of the colon and rectum: potential effects of sex-age
                    interactions on incidence and outcome. Med Sci Monit. 19:203-9.
                31. Wu QJ, Vogtmann E, Zhang W, Xie L, Yang WS, Tan YT, et al. (2012) Cancer incidence among ado-
                    lescents and young adults in urban Shanghai, 1973-2005. PLoS One. 7(8): e42607.
                32. Brenner H, Kloor M, Pox CP. (2014) Colorectal cancer. Lancet. 383(9927):1490-502.
                33. Karanikas M, Esebidis A. (2016) Increasing incidence of colon cancer in patients <50 years old: a new
                    entity? Ann Transl Med. 4(9):164.
                34. Fedewa SA, Ma J, Sauer AG, Siegel RL, Smith RA, Wender RC, et al. (2015) How many individuals
                    will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018? Cancer.
                    121(23):4258-65.
                35. Deschoolmeester V, Boeckx C, Baay M, Weyler J, Wuyts W, Van Marck E, et al. (2010) KRAS mu-
                    tation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting
                    analysis. Br J Cancer. 103(10):1627-36.
                36. Krivokapic Z, Markovic S, Antic J, Dimitrijevic I, Bojic D, Svorcan P, et al. (2012) Clinical and patho-
                    logical tools for identifying microsatellite instability in colorectal cancer. Croat Med J. 53(4):328-35.
                37. Raskin L, Dakubo JC, Palaski N, Greenson JK, Gruber SB. (2013) Distinct molecular features of colo-
                    rectal cancer in Ghana. Cancer Epidemiol. 37(5):556-61.
                38. Sorbye H, Dragomir A, Sundstrom M, Pfeiffer P, Thunberg U, Bergfors M, et al. (2015) High BRAF
                    Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mu-
                    tation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal
                    Cancer Cohort. PLoS One. 10(6): e0131046.
                39. Ogino S, Goel A. (2008) Molecular classifi cation and correlates in colorectal cancer. J mol diagn.
                    10(1):13-27.
                40. Nazemalhosseini Mojarad E, Kashfi  SM, Mirtalebi H, Taleghani MY, Azimzadeh P, Savabkar S, et




         96
                                                                               Rev. Asoc. Col. Cienc.(Col.), 2019; 31: 87-99
   91   92   93   94   95   96   97   98   99   100   101